Edward Nirenberg on Nostr: I'm not sure why you'd bother. Admittedly, a monoclonal antibody targets a single ...
I'm not sure why you'd bother.
Admittedly, a monoclonal antibody targets a single epitope and so the potential for resistance to evolve is MUCH higher than with a vaccine which induces a polyclonal response. A few well-placed substitutions and binding is abolished.
Published at
2024-06-28 15:59:55Event JSON
{
"id": "846fe7bc99374497c7a442d288ede5cd5bdf08089ccadb9797c2e188ce658bbc",
"pubkey": "c67b38e4c5023e985f04ae7ab6a6669cf463220e1b9ed54b897d1957004603a4",
"created_at": 1719590395,
"kind": 1,
"tags": [
[
"e",
"f5febefd46b73510239fb02554ed48b5e6d2ced230521b63d2486c2fcb19a6bc",
"wss://relay.mostr.pub",
"reply"
],
[
"proxy",
"https://med-mastodon.com/users/enirenberg/statuses/112695076151959563",
"activitypub"
]
],
"content": "I'm not sure why you'd bother.\n\nAdmittedly, a monoclonal antibody targets a single epitope and so the potential for resistance to evolve is MUCH higher than with a vaccine which induces a polyclonal response. A few well-placed substitutions and binding is abolished.",
"sig": "5c6cc4e450b7b1cdd59f34b40642b394273195c28deaffe8f959f72d6f0473a2232e7442cffca05b0be0b37b85772e5276be0f3185633a6c1632c227d24d0144"
}
